Digital Pathology Market is expected to reach US$ 1,892.40 Million by 2028

Scanners Segment to Lead Market during 2022–2028

According to our new research study on "Digital Pathology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Type, Application, and End User," the digital pathology market is expected to grow from US$ 952.62 million in 2022 to US$ 1,892.40 million by 2028; it is estimated to grow at a CAGR of 12.1% from 2022 to 2028. The report highlights the trends and drivers prevailing in the market. The rising adoption of digital pathology to enhance lab efficiency and growing applications of digital pathology in drug development and companion diagnostics. However, the high costs involvd in digital pathology systems hamper the growth of the digital pathology market.

Based on product, the digital pathology market is segmented into scanner, software, storage, and communication system. The scanner segment is further bifurcated into integrated and standalone. The scanner segment is likely to held the largest market share in 2022. However, the software segment is expected to register the highest CAGR during the forecast period. Based on type, the digital pathology market is bifurcated into human pathology and veterinary pathology. The human pathology segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period. Based on application, the digital pathology market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period. Based on end user, the digital pathology market is segmented into pharma & biotech companies, hospitals, and academics. The pharma & biotech companies segment held the largest market share in 2021 and is estimated to register the highest CAGR during the forecast period.

Digital Pathology Market

Impact of COVID-19 Pandemic on Digital Pathology Market

The COVID-19 pandemic has highlighted the criticality of health in social and economic growth, reinforcing the need for greater health investments to secure people's wellbeing and build long-term health systems around the world. Pathologists are essential employees that play a vital role in the COVID-19 crisis response and day-to-day hospital operations. Being front-line workforce puts them at a greater risk of exposure to SARS-CoV-2, further subjecting their families and social circles to an elevated risk of infection. In May 2020, Indica Labs, a provider of computational pathology software, and Octo, an information technology systems provider to the US Federal Government, announced the online COVID digital pathology repository (COVID-DPR), a virtual collection of high-resolution microscopic COVID-related human tissue images, hosted at the National Institutes of Health (NIH). The whole slide images, annotations, and metadata in the repository will be used as a reference data set for education, research, and clinical trials focusing on irradicating the disease. The COVID-DPR will be available immediately as a shared resource for researchers at institutes worldwide, with initial data sets being provided by laboratories studying infectious diseases across North America, Europe, and Australia.

Several players in the digital pathology market—including Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation are engaged in addressing the growing demands for digital pathology solutions. 

The report segments the digital pathology market as follows:

The digital pathology market is segmented on the basis of product, type, application, and end user. Based on product, the digital pathology market is segmented into scanner, software, storage, and communication systems. Based on type, the digital pathology market is bifurcated into human pathology and veterinary pathology. Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. Based on end user, the market is segmented into pharma and biotech companies, hospitals, and academics. Based on geography, the digital pathology market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).